# Neurocrine is paying $145,000 per patient for a drug that works

- slug: neurocrine-is-paying-145000-per-patient-for-a-drug-that-works
- date: 2026-04-06
- category: Biotech & Life Sciences

$2.9B for Soleno means $100K+ per patient annually, for a drug with no competition and 20,000 US patients. The access question is who absorbs that cost — and what happens when they cannot.

---